pmid,pmcid,title,journal,insert_time,has_targz
19543491,PMC2698621,Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience.,Korean J Intern Med,2024-02-14-09-13-23,True
19543491,PMC2698621,Clinicopathologic characteristics of T-cell non-Hodgkin's lymphoma: a single institution experience.,Korean J Intern Med,2024-02-14-09-13-26,True
21234094,PMC3018635,"Extranodal natural-killer/t-cell lymphoma, nasal type.",Adv Hematol,2024-02-14-09-13-23,True
21234094,PMC3018635,"Extranodal natural-killer/t-cell lymphoma, nasal type.",Adv Hematol,2024-02-14-09-13-26,True
21541194,PMC3085502,Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.,J Biomed Biotechnol,2024-02-14-09-13-26,True
21541194,PMC3085502,Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.,J Biomed Biotechnol,2024-02-14-09-13-23,True
21731288,PMC3125667,"Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology.",J Oral Maxillofac Pathol,2024-02-14-09-13-23,True
21731288,PMC3125667,"Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology.",J Oral Maxillofac Pathol,2024-02-14-09-13-26,True
21854649,PMC3179701,"Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.",Diagn Pathol,2024-02-14-09-13-23,True
21854649,PMC3179701,"Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.",Diagn Pathol,2024-02-14-09-13-26,True
21867533,PMC3170575,Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.,Diagn Pathol,2024-02-14-09-13-23,True
21867533,PMC3170575,Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.,Diagn Pathol,2024-02-14-09-13-26,True
21912510,PMC3164152,Circulating and tumor-infiltrating Foxp3⁺ regulatory T cell subset in Chinese patients with extranodal NK/T cell lymphoma.,Int J Biol Sci,2024-02-14-09-13-26,True
21912510,PMC3164152,Circulating and tumor-infiltrating Foxp3⁺ regulatory T cell subset in Chinese patients with extranodal NK/T cell lymphoma.,Int J Biol Sci,2024-02-14-09-13-23,True
22184541,PMC3238481,Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement.,Hematol Rep,2024-02-14-09-13-26,True
22184541,PMC3238481,Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement.,Hematol Rep,2024-02-14-09-13-23,True
22323887,PMC3268170,Intraocular involvement of a nasal natural killer T-cell lymphoma: a case report.,Korean J Ophthalmol,2024-02-14-09-13-26,True
22323887,PMC3268170,Intraocular involvement of a nasal natural killer T-cell lymphoma: a case report.,Korean J Ophthalmol,2024-02-14-09-13-23,True
22682004,PMC3416641,Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-26,True
22682004,PMC3416641,Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-23,True
22844610,PMC3403505,Cutaneous T-cell lymphoma in asians.,ISRN Dermatol,2024-02-14-09-13-26,True
22844610,PMC3403505,Cutaneous T-cell lymphoma in asians.,ISRN Dermatol,2024-02-14-09-13-23,True
22931631,PMC3487841,NK/T-cell lymphoma of bilateral adrenal glands in a patient with pyothorax.,Diagn Pathol,2024-02-14-09-13-26,True
22931631,PMC3487841,NK/T-cell lymphoma of bilateral adrenal glands in a patient with pyothorax.,Diagn Pathol,2024-02-14-09-13-23,True
23031227,PMC3502398,CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.,Diagn Pathol,2024-02-14-09-13-23,True
23031227,PMC3502398,CD20-positive NK/T-cell lymphoma with indolent clinical course: report of case and review of literature.,Diagn Pathol,2024-02-14-09-13-26,True
23071475,PMC3464337,Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?,Korean J Hematol,2024-02-14-09-13-26,True
23071475,PMC3464337,Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?,Korean J Hematol,2024-02-14-09-13-23,True
23109994,PMC3479788,"Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas.",Korean J Pathol,2024-02-14-09-13-26,True
23109994,PMC3479788,"Expression of HAT1 and HDAC1, 2, 3 in Diffuse Large B-Cell Lymphomas, Peripheral T-Cell Lymphomas, and NK/T-Cell Lymphomas.",Korean J Pathol,2024-02-14-09-13-23,True
23237707,PMC3539909,"LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).",Diagn Pathol,2024-02-14-09-13-23,True
23237707,PMC3539909,"LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL).",Diagn Pathol,2024-02-14-09-13-26,True
23327615,PMC3564726,"Extranodal natural killer/T-cell lymphoma, nasal type: 'midline lethal granuloma.' A case report.",Head Face Med,2024-02-14-09-13-23,True
23327615,PMC3564726,"Extranodal natural killer/T-cell lymphoma, nasal type: 'midline lethal granuloma.' A case report.",Head Face Med,2024-02-14-09-13-26,True
23569495,PMC3615940,Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.,Am J Case Rep,2024-02-14-09-13-23,True
23569495,PMC3615940,Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.,Am J Case Rep,2024-02-14-09-13-26,True
23772308,PMC3682461,Primary NK/T cell lymphoma nasal type of the colon.,Rare Tumors,2024-02-14-09-13-23,True
23772308,PMC3682461,Primary NK/T cell lymphoma nasal type of the colon.,Rare Tumors,2024-02-14-09-13-26,True
23773344,PMC3707818,"An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature.",Diagn Pathol,2024-02-14-09-13-23,True
23773344,PMC3707818,"An extraordinary T/NK lymphoma, nasal type, occurring primarily in the prostate gland with unusual CD30 positivity: case report and review of the literature.",Diagn Pathol,2024-02-14-09-13-26,True
23816178,PMC3734195,"A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.",J Hematol Oncol,2024-02-14-09-13-23,True
23816178,PMC3734195,"A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.",J Hematol Oncol,2024-02-14-09-13-26,True
24238138,PMC4225665,Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.,J Hematol Oncol,2024-02-14-09-13-26,True
24238138,PMC4225665,Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.,J Hematol Oncol,2024-02-14-09-13-23,True
24438193,PMC3898819,"The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.",J Exp Clin Cancer Res,2024-02-14-09-13-26,True
24438193,PMC3898819,"The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.",J Exp Clin Cancer Res,2024-02-14-09-13-23,True
24466552,PMC3894386,"Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.",Blood Res,2024-02-14-09-13-23,True
24466552,PMC3894386,"Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.",Blood Res,2024-02-14-09-13-26,True
24712440,PMC4317897,Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.,Cancer Sci,2024-02-14-09-13-26,True
24712440,PMC4317897,Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.,Cancer Sci,2024-02-14-09-13-23,True
24722378,PMC3983224,Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.,PLoS One,2024-02-14-09-13-23,True
24722378,PMC3983224,Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.,PLoS One,2024-02-14-09-13-26,True
24886075,PMC4052815,"Primary extranodal NK/T cell lymphoma, nasal-type of uterus with adenomyosis: a case report.",Diagn Pathol,2024-02-14-09-13-26,True
24886075,PMC4052815,"Primary extranodal NK/T cell lymphoma, nasal-type of uterus with adenomyosis: a case report.",Diagn Pathol,2024-02-14-09-13-23,True
24952511,PMC4079938,"High-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression.",Med Oncol,2024-02-14-09-13-23,True
24952511,PMC4079938,"High-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression.",Med Oncol,2024-02-14-09-13-26,True
25181936,PMC4462380,Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.,Cancer Sci,2024-02-14-09-13-23,True
25181936,PMC4462380,Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.,Cancer Sci,2024-02-14-09-13-26,True
25183183,PMC9444635,"Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type.",Braz J Otorhinolaryngol,2024-02-14-09-13-26,True
25183183,PMC9444635,"Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type.",Braz J Otorhinolaryngol,2024-02-14-09-13-23,True
25183396,PMC4167522,"Primary spleen extranodal NK/T cell lymphoma, nasal type, with bone marrow involvement and CD30 positive expression: a case report and literature review.",Diagn Pathol,2024-02-14-09-13-26,True
25183396,PMC4167522,"Primary spleen extranodal NK/T cell lymphoma, nasal type, with bone marrow involvement and CD30 positive expression: a case report and literature review.",Diagn Pathol,2024-02-14-09-13-23,True
25289105,PMC4186554,"Extranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.",Oncol Lett,2024-02-14-09-13-26,True
25289105,PMC4186554,"Extranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.",Oncol Lett,2024-02-14-09-13-23,True
25501024,PMC4315894,"Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma.",Blood Cancer J,2024-02-14-09-13-23,True
25501024,PMC4315894,"Concurrent IMRT and weekly cisplatin followed by GDP chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell lymphoma.",Blood Cancer J,2024-02-14-09-13-26,True
25793085,PMC4349107,"Clinico-radiologic findings in primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type mimicking cellulitis of the left arm.",Iran J Radiol,2024-02-14-09-13-23,True
25793085,PMC4349107,"Clinico-radiologic findings in primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type mimicking cellulitis of the left arm.",Iran J Radiol,2024-02-14-09-13-26,True
25887673,PMC4336495,Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.,J Exp Clin Cancer Res,2024-02-14-09-13-23,True
25887673,PMC4336495,Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma.,J Exp Clin Cancer Res,2024-02-14-09-13-26,True
25966773,PMC4437674,The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.,J Hematol Oncol,2024-02-14-09-13-23,True
25966773,PMC4437674,The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.,J Hematol Oncol,2024-02-14-09-13-26,True
25980440,PMC4627344,Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.,Oncotarget,2024-02-14-09-13-26,True
25980440,PMC4627344,Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.,Oncotarget,2024-02-14-09-13-23,True
26017177,PMC4817864,Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.,Mol Ther,2024-02-14-09-13-26,True
26017177,PMC4817864,Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.,Mol Ther,2024-02-14-09-13-23,True
26120182,PMC4458969,Extranodal NK/T-cell Lymphoma Mimicking Erythema Multiforme.,Indian J Dermatol,2024-02-14-09-13-23,True
26120182,PMC4458969,Extranodal NK/T-cell Lymphoma Mimicking Erythema Multiforme.,Indian J Dermatol,2024-02-14-09-13-26,True
26141723,PMC4491245,Aggressive natural killer-cell neoplasm presenting in the marrow: a report of two cases including one with gains of chromosomes 4q and 9p.,Diagn Pathol,2024-02-14-09-13-26,True
26141723,PMC4491245,Aggressive natural killer-cell neoplasm presenting in the marrow: a report of two cases including one with gains of chromosomes 4q and 9p.,Diagn Pathol,2024-02-14-09-13-23,True
26181557,PMC4617074,Primary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature Review.,Medicine (Baltimore),2024-02-14-09-13-26,True
26181557,PMC4617074,Primary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature Review.,Medicine (Baltimore),2024-02-14-09-13-23,True
26210287,PMC4745801,Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.,Oncotarget,2024-02-14-09-13-26,True
26210287,PMC4745801,Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.,Oncotarget,2024-02-14-09-13-23,True
26221594,PMC4499638,"The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.",Biomed Res Int,2024-02-14-09-13-23,True
26221594,PMC4499638,"The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.",Biomed Res Int,2024-02-14-09-13-26,True
26396532,PMC4576888,Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.,Onco Targets Ther,2024-02-14-09-13-23,True
26396532,PMC4576888,Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy.,Onco Targets Ther,2024-02-14-09-13-26,True
26449540,PMC4599775,Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.,J Hematol Oncol,2024-02-14-09-13-26,True
26449540,PMC4599775,Erratum to: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.,J Hematol Oncol,2024-02-14-09-13-23,True
26497849,PMC4643115,Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.,Cancer Immunol Immunother,2024-02-14-09-13-26,True
26497849,PMC4643115,Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.,Cancer Immunol Immunother,2024-02-14-09-13-23,True
26512181,PMC4622901,"CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement.",Ann Dermatol,2024-02-14-09-13-26,True
26512181,PMC4622901,"CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement.",Ann Dermatol,2024-02-14-09-13-23,True
26668464,PMC4668745,NHL - Extranodal T-cell lymphoma.,Natl J Maxillofac Surg,2024-02-14-09-13-26,True
26668464,PMC4668745,NHL - Extranodal T-cell lymphoma.,Natl J Maxillofac Surg,2024-02-14-09-13-23,True
26770278,PMC4702053,Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.,GMS Curr Top Otorhinolaryngol Head Neck Surg,2024-02-14-09-13-23,True
26770278,PMC4702053,Orphan diseases of the nose and paranasal sinuses: Pathogenesis - clinic - therapy.,GMS Curr Top Otorhinolaryngol Head Neck Surg,2024-02-14-09-13-26,True
26770954,PMC4705052,Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin.,Blood Res,2024-02-14-09-13-26,True
26770954,PMC4705052,Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin.,Blood Res,2024-02-14-09-13-23,True
26816549,PMC4718123,Primary extranodal natural killer/T-cell lymphoma of bronchus and lung: A case report and review of literature.,Thorac Cancer,2024-02-14-09-13-23,True
26816549,PMC4718123,Primary extranodal natural killer/T-cell lymphoma of bronchus and lung: A case report and review of literature.,Thorac Cancer,2024-02-14-09-13-26,True
26824008,PMC4725674,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as a Breast Mass.",Cureus,2024-02-14-09-13-26,True
26824008,PMC4725674,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as a Breast Mass.",Cureus,2024-02-14-09-13-23,True
26986167,PMC4839948,Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.,Medicine (Baltimore),2024-02-14-09-13-26,True
26986167,PMC4839948,Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.,Medicine (Baltimore),2024-02-14-09-13-23,True
27021626,PMC4810364,S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.,Sci Rep,2024-02-14-09-13-26,True
27021626,PMC4810364,S100A9 and ORM1 serve as predictors of therapeutic response and prognostic factors in advanced extranodal NK/T cell lymphoma patients treated with pegaspargase/gemcitabine.,Sci Rep,2024-02-14-09-13-23,True
27051293,PMC4803244,"Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type.",Onco Targets Ther,2024-02-14-09-13-26,True
27051293,PMC4803244,"Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type.",Onco Targets Ther,2024-02-14-09-13-23,True
27072578,PMC5085239,"Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-26,True
27072578,PMC5085239,"Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-23,True
27093153,PMC5045380,"Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-26,True
27093153,PMC5045380,"Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-23,True
27105512,PMC5078073,High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.,Oncotarget,2024-02-14-09-13-23,True
27105512,PMC5078073,High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients.,Oncotarget,2024-02-14-09-13-26,True
27192524,PMC4861572,Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.,An Bras Dermatol,2024-02-14-09-13-23,True
27192524,PMC4861572,Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.,An Bras Dermatol,2024-02-14-09-13-20,True
27192524,PMC4861572,Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.,An Bras Dermatol,2024-02-14-09-13-26,True
27239439,PMC4821355,miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.,FEBS Open Bio,2024-02-14-09-13-23,True
27239439,PMC4821355,miRNA expression profiling of Epstein-Barr virus-associated NKTL cell lines by Illumina deep sequencing.,FEBS Open Bio,2024-02-14-09-13-26,True
27483437,PMC4970793,Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.,PLoS One,2024-02-14-09-13-23,True
27483437,PMC4970793,Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.,PLoS One,2024-02-14-09-13-26,True
27493813,PMC4967471,Extranodal NK/T Cell Lymphoma Causing Cardiorespiratory Failure.,Case Rep Hematol,2024-02-14-09-13-23,True
27493813,PMC4967471,Extranodal NK/T Cell Lymphoma Causing Cardiorespiratory Failure.,Case Rep Hematol,2024-02-14-09-13-26,True
27534792,PMC5321187,Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.,J Radiat Res,2024-02-14-09-13-23,True
27534792,PMC5321187,Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma.,J Radiat Res,2024-02-14-09-13-26,True
27542213,PMC5356760,"Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).",Oncotarget,2024-02-14-09-13-26,True
27542213,PMC5356760,"Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).",Oncotarget,2024-02-14-09-13-23,True
27713641,PMC5045225,Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy.,Onco Targets Ther,2024-02-14-09-13-23,True
27713641,PMC5045225,Radiation dose reduction for patients with extranodal NK/T-cell lymphoma with complete response after initial induction chemotherapy.,Onco Targets Ther,2024-02-14-09-13-26,True
27723108,PMC5763273,"A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.",Hematol Oncol,2024-02-14-09-13-26,True
27723108,PMC5763273,"A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.",Hematol Oncol,2024-02-14-09-13-23,True
27729836,PMC5056900,Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel.,Genomics Inform,2024-02-14-09-13-26,True
27729836,PMC5056900,Mutational Analysis of Extranodal NK/T-Cell Lymphoma Using Targeted Sequencing with a Comprehensive Cancer Panel.,Genomics Inform,2024-02-14-09-13-23,True
27843135,PMC5117239,Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.,Med Sci Monit,2024-02-14-09-13-26,True
27843135,PMC5117239,Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.,Med Sci Monit,2024-02-14-09-13-23,True
27901491,PMC5386768,A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.,Oncotarget,2024-02-14-09-13-23,True
27901491,PMC5386768,A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.,Oncotarget,2024-02-14-09-13-26,True
27974685,PMC5352093,Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma.,Oncotarget,2024-02-14-09-13-26,True
27974685,PMC5352093,Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma.,Oncotarget,2024-02-14-09-13-23,True
28057019,PMC5217200,Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-23,True
28057019,PMC5217200,Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-26,True
28088979,PMC7348500,[Value of PET-CT clinical application in extranodal NK/T cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
28088979,PMC7348500,[Value of PET-CT clinical application in extranodal NK/T cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
28193996,PMC5319307,A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.,Am J Case Rep,2024-02-14-09-13-26,True
28193996,PMC5319307,A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.,Am J Case Rep,2024-02-14-09-13-23,True
28194321,PMC5296617,Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis.,GMS Ophthalmol Cases,2024-02-14-09-13-26,True
28194321,PMC5296617,Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis.,GMS Ophthalmol Cases,2024-02-14-09-13-23,True
28222648,PMC5536587,Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.,J Int Med Res,2024-02-14-09-13-23,True
28222648,PMC5536587,Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.,J Int Med Res,2024-02-14-09-13-26,True
28346502,PMC5367708,EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.,PLoS One,2024-02-14-09-13-26,True
28346502,PMC5367708,EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.,PLoS One,2024-02-14-09-13-23,True
28382141,PMC5381167,"Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type.",J Cancer,2024-02-14-09-13-26,True
28382141,PMC5381167,"Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type.",J Cancer,2024-02-14-09-13-23,True
28393058,PMC5380396,Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report.,Iran J Otorhinolaryngol,2024-02-14-09-13-23,True
28393058,PMC5380396,Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report.,Iran J Otorhinolaryngol,2024-02-14-09-13-26,True
28404973,PMC5564839,"A phase II prospective study of the ""Sandwich"" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-26,True
28404973,PMC5564839,"A phase II prospective study of the ""Sandwich"" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-20,True
28404973,PMC5564839,"A phase II prospective study of the ""Sandwich"" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.",Oncotarget,2024-02-14-09-13-23,True
28410601,PMC5391564,The diagnosis and management of NK/T-cell lymphomas.,J Hematol Oncol,2024-02-14-09-13-26,True
28410601,PMC5391564,The diagnosis and management of NK/T-cell lymphomas.,J Hematol Oncol,2024-02-14-09-13-23,True
28471978,PMC5419924,"Septicemia and pneumonia due to Mycobacterium fortuitum infection in a patient with extronodal NK/T-cell lymphoma, nasal type: A case report.",Medicine (Baltimore),2024-02-14-09-13-23,True
28471978,PMC5419924,"Septicemia and pneumonia due to Mycobacterium fortuitum infection in a patient with extronodal NK/T-cell lymphoma, nasal type: A case report.",Medicine (Baltimore),2024-02-14-09-13-26,True
28486951,PMC5424426,"CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.",Chin J Cancer,2024-02-14-09-13-23,True
28486951,PMC5424426,"CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.",Chin J Cancer,2024-02-14-09-13-26,True
28529614,PMC5436254,IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.,J Cancer,2024-02-14-09-13-23,True
28529614,PMC5436254,IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.,J Cancer,2024-02-14-09-13-26,True
28550598,PMC5486802,Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.,Ann Hematol,2024-02-14-09-13-23,True
28550598,PMC5486802,Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.,Ann Hematol,2024-02-14-09-13-26,True
28566607,PMC5498208,Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.,Intern Med,2024-02-14-09-13-23,True
28566607,PMC5498208,Development of Extranodal NK/T-cell Lymphoma Nasal Type in Cerebrum Following Epstein-Barr Virus-positive Uveitis.,Intern Med,2024-02-14-09-13-26,True
28623913,PMC5474018,Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.,Diagn Pathol,2024-02-14-09-13-26,True
28623913,PMC5474018,Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement.,Diagn Pathol,2024-02-14-09-13-23,True
28672968,PMC5488386,Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms.,Exp Ther Med,2024-02-14-09-13-23,True
28672968,PMC5488386,Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms.,Exp Ther Med,2024-02-14-09-13-26,True
28675023,PMC6056977,"Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.",Cancer Res Treat,2024-02-14-09-13-26,True
28675023,PMC6056977,"Comparison of Native Escherichia coli L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell Lymphoma, Nasal Type.",Cancer Res Treat,2024-02-14-09-13-23,True
28748192,PMC5507379,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as Refractory Pseudomonas aeruginosa Facial Cellulitis.",J Investig Med High Impact Case Rep,2024-02-14-09-13-23,True
28748192,PMC5507379,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Presenting as Refractory Pseudomonas aeruginosa Facial Cellulitis.",J Investig Med High Impact Case Rep,2024-02-14-09-13-26,True
28768972,PMC5577078,"Extranodal NK/T-cell Lymphoma, Nasal Type Accompanied by PR3-ANCA-associated Glomerulonephritis.",Intern Med,2024-02-14-09-13-23,True
28768972,PMC5577078,"Extranodal NK/T-cell Lymphoma, Nasal Type Accompanied by PR3-ANCA-associated Glomerulonephritis.",Intern Med,2024-02-14-09-13-26,True
28855986,PMC5574062,Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine.,Mol Clin Oncol,2024-02-14-09-13-23,True
28855986,PMC5574062,Treatment of relapsed extranodal natural killer/T-cell lymphoma with bortezomib plus fludarabine.,Mol Clin Oncol,2024-02-14-09-13-26,True
28858104,PMC5585498,Oral and maxillofacial non-Hodgkin lymphomas: Case report with review of literature.,Medicine (Baltimore),2024-02-14-09-13-26,True
28858104,PMC5585498,Oral and maxillofacial non-Hodgkin lymphomas: Case report with review of literature.,Medicine (Baltimore),2024-02-14-09-13-23,True
28858104,PMC5585498,Oral and maxillofacial non-Hodgkin lymphomas: Case report with review of literature.,Medicine (Baltimore),2024-02-14-09-13-20,True
28877678,PMC5588687,Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.,BMC Cancer,2024-02-14-09-13-23,True
28877678,PMC5588687,Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.,BMC Cancer,2024-02-14-09-13-26,True
28913276,PMC5556807,Recurrent Extranodal NK/T-Cell Lymphoma Presenting as a Perforating Palatal Ulcer and Oro-Nasal Fistula.,Arch Craniofac Surg,2024-02-14-09-13-23,True
28913276,PMC5556807,Recurrent Extranodal NK/T-Cell Lymphoma Presenting as a Perforating Palatal Ulcer and Oro-Nasal Fistula.,Arch Craniofac Surg,2024-02-14-09-13-26,True
28950914,PMC5615630,Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.,J Exp Clin Cancer Res,2024-02-14-09-13-23,True
28950914,PMC5615630,Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.,J Exp Clin Cancer Res,2024-02-14-09-13-26,True
29085199,PMC5643275,Gastrosplenic fistula occurring in lymphoma patients: Systematic review with a new case of extranodal NK/T-cell lymphoma.,World J Gastroenterol,2024-02-14-09-13-26,True
29085199,PMC5643275,Gastrosplenic fistula occurring in lymphoma patients: Systematic review with a new case of extranodal NK/T-cell lymphoma.,World J Gastroenterol,2024-02-14-09-13-23,True
29097495,PMC5792272,Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.,Haematologica,2024-02-14-09-13-23,True
29097495,PMC5792272,Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes.,Haematologica,2024-02-14-09-13-26,True
29166501,PMC5674697,Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.,An Bras Dermatol,2024-02-14-09-13-26,True
29166501,PMC5674697,Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute.,An Bras Dermatol,2024-02-14-09-13-23,True
29242302,PMC6058795,A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.,Haematologica,2024-02-14-09-13-23,True
29242302,PMC6058795,A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.,Haematologica,2024-02-14-09-13-26,True
29245256,PMC5728871,Primary pulmonary extranodal NK/T-cell lymphoma of nasal type misdiagnosed as pneumonia: A case report and literature review.,Medicine (Baltimore),2024-02-14-09-13-23,True
29245256,PMC5728871,Primary pulmonary extranodal NK/T-cell lymphoma of nasal type misdiagnosed as pneumonia: A case report and literature review.,Medicine (Baltimore),2024-02-14-09-13-26,True
29363227,PMC5891177,Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.,Cancer Sci,2024-02-14-09-13-26,True
29363227,PMC5891177,Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.,Cancer Sci,2024-02-14-09-13-23,True
29455176,PMC5836627,"Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.",BMJ Case Rep,2024-02-14-09-13-23,True
29455176,PMC5836627,"Late diagnosis: a case of rapidly progressive extranodal NK/T cell lymphoma, nasal type.",BMJ Case Rep,2024-02-14-09-13-26,True
29482573,PMC5828429,Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.,Diagn Pathol,2024-02-14-09-13-26,True
29482573,PMC5828429,Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.,Diagn Pathol,2024-02-14-09-13-23,True
29518976,PMC5874754,EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.,Pathogens,2024-02-14-09-13-23,True
29518976,PMC5874754,EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts.,Pathogens,2024-02-14-09-13-26,True
29520150,PMC5833780,Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.,Onco Targets Ther,2024-02-14-09-13-23,True
29520150,PMC5833780,Prognostic significance of Epstein-Barr virus DNA in NK/T-cell lymphoma: a meta-analysis.,Onco Targets Ther,2024-02-14-09-13-26,True
29636962,PMC5889251,Blastic plasmacytoid dendritic cell neoplasm.,Clin Case Rep,2024-02-14-09-13-26,True
29636962,PMC5889251,Blastic plasmacytoid dendritic cell neoplasm.,Clin Case Rep,2024-02-14-09-13-23,True
29662666,PMC5893261,CD30 expression and survival in extranodal NK/T-cell lymphoma: a systematic review and meta-analysis.,Oncotarget,2024-02-14-09-13-26,True
29662666,PMC5893261,CD30 expression and survival in extranodal NK/T-cell lymphoma: a systematic review and meta-analysis.,Oncotarget,2024-02-14-09-13-23,True
29674644,PMC5908809,Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.,Nat Commun,2024-02-14-09-13-26,True
29674644,PMC5908809,Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.,Nat Commun,2024-02-14-09-13-23,True
29761078,PMC5937056,Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.,Front Oncol,2024-02-14-09-13-23,True
29761078,PMC5937056,Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.,Front Oncol,2024-02-14-09-13-26,True
29764116,PMC6333979,Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.,Cancer Res Treat,2024-02-14-09-13-23,True
29764116,PMC6333979,Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.,Cancer Res Treat,2024-02-14-09-13-26,True
29779331,PMC7342138,[The expression and role of 14-3-3ζ protein in advanced extranodal NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
29779331,PMC7342138,[The expression and role of 14-3-3ζ protein in advanced extranodal NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
29888018,PMC5977006,"Comparison of Diagnostic Cytomorphology of Natural Killer/T-Cell Lymphoma (Nasal Type) in Conventional Smears, Liquid-Based Preparations, and Histopathology.",Case Rep Pathol,2024-02-14-09-13-23,True
29888018,PMC5977006,"Comparison of Diagnostic Cytomorphology of Natural Killer/T-Cell Lymphoma (Nasal Type) in Conventional Smears, Liquid-Based Preparations, and Histopathology.",Case Rep Pathol,2024-02-14-09-13-26,True
29922069,PMC5995429,"Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE-IIE extranodal natural killer/T-cell lymphoma, nasal type.",Ther Clin Risk Manag,2024-02-14-09-13-26,True
29922069,PMC5995429,"Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE-IIE extranodal natural killer/T-cell lymphoma, nasal type.",Ther Clin Risk Manag,2024-02-14-09-13-23,True
29924244,PMC6001101,Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome.,An Bras Dermatol,2024-02-14-09-13-23,True
29924244,PMC6001101,Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome.,An Bras Dermatol,2024-02-14-09-13-26,True
29966370,PMC6073933,The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.,Int J Mol Sci,2024-02-14-09-13-23,True
29966370,PMC6073933,The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.,Int J Mol Sci,2024-02-14-09-13-26,True
29978138,PMC6026719,A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement.,Am J Ophthalmol Case Rep,2024-02-14-09-13-26,True
29978138,PMC6026719,A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement.,Am J Ophthalmol Case Rep,2024-02-14-09-13-23,True
30045301,PMC6078727,A case report of extranodal NK/T-cell lymphoma in patient with chronic lymphocytic leukemia.,Medicine (Baltimore),2024-02-14-09-13-23,True
30045301,PMC6078727,A case report of extranodal NK/T-cell lymphoma in patient with chronic lymphocytic leukemia.,Medicine (Baltimore),2024-02-14-09-13-26,True
30076184,PMC6269314,Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.,Haematologica,2024-02-14-09-13-23,True
30076184,PMC6269314,Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma.,Haematologica,2024-02-14-09-13-26,True
30122016,PMC7342215,[Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
30122016,PMC7342215,[Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-20,True
30122016,PMC7342215,[Clinical analysis of autologous hematopoietic stem cell transplantation in the treatment of advanced/recurrent nasal type extranodal NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
30142852,PMC6112938,"Extranodal natural killer/T cell lymphoma, nasal type in the middle cranial fossa: A case report.",Medicine (Baltimore),2024-02-14-09-13-26,True
30142852,PMC6112938,"Extranodal natural killer/T cell lymphoma, nasal type in the middle cranial fossa: A case report.",Medicine (Baltimore),2024-02-14-09-13-23,True
30146568,PMC6378152,Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis.,Intern Med,2024-02-14-09-13-23,True
30146568,PMC6378152,Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis.,Intern Med,2024-02-14-09-13-26,True
30151671,PMC6267266,"Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.",Virchows Arch,2024-02-14-09-13-26,True
30151671,PMC6267266,"Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.",Virchows Arch,2024-02-14-09-13-23,True
30241515,PMC6151061,PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.,BMC Cancer,2024-02-14-09-13-26,True
30241515,PMC6151061,PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.,BMC Cancer,2024-02-14-09-13-23,True
30302057,PMC6167813,Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?,Cancer Cell Int,2024-02-14-09-13-26,True
30302057,PMC6167813,Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?,Cancer Cell Int,2024-02-14-09-13-23,True
30310787,PMC6170315,"Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience.",Blood Res,2024-02-14-09-13-26,True
30310787,PMC6170315,"Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience.",Blood Res,2024-02-14-09-13-23,True
30356034,PMC6213871,"Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.",Med Sci Monit,2024-02-14-09-13-26,True
30356034,PMC6213871,"Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type.",Med Sci Monit,2024-02-14-09-13-23,True
30464606,PMC6214348,"Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study.",Cancer Manag Res,2024-02-14-09-13-23,True
30464606,PMC6214348,"Pegaspargase, gemcitabine, dexamethasone, and cisplatin (P-GDP) combined chemotherapy is effective for newly diagnosed extranodal NK/T-cell lymphoma: a retrospective study.",Cancer Manag Res,2024-02-14-09-13-26,True
30470245,PMC6260989,"Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.",Diagn Pathol,2024-02-14-09-13-23,True
30470245,PMC6260989,"Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.",Diagn Pathol,2024-02-14-09-13-26,True
30486597,PMC7342350,[Hemophagocytic lymphohistiocytosis following autologous hematopoietic stem cell transplantation for advanced extranodal NK/T-cell lymphoma: a case report and literatures review].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
30486597,PMC7342350,[Hemophagocytic lymphohistiocytosis following autologous hematopoietic stem cell transplantation for advanced extranodal NK/T-cell lymphoma: a case report and literatures review].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
30515337,PMC6234446,Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma.,Case Rep Hematol,2024-02-14-09-13-26,True
30515337,PMC6234446,Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma.,Case Rep Hematol,2024-02-14-09-13-23,True
30567593,PMC6300911,"Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.",J Hematol Oncol,2024-02-14-09-13-26,True
30567593,PMC6300911,"Treatment of localized extranodal NK/T cell lymphoma, nasal type: a systematic review.",J Hematol Oncol,2024-02-14-09-13-23,True
30603836,PMC6543026,An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct.,Clin J Gastroenterol,2024-02-14-09-13-26,True
30603836,PMC6543026,An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct.,Clin J Gastroenterol,2024-02-14-09-13-23,True
30612403,PMC7348219,[PRDM1 expression and its relationship with PI3K/AKT pathway activation in extranodal NK/T cell lymphoma-nasal type].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
30612403,PMC7348219,[PRDM1 expression and its relationship with PI3K/AKT pathway activation in extranodal NK/T cell lymphoma-nasal type].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
30662890,PMC6328478,Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.,Front Pediatr,2024-02-14-09-13-26,True
30662890,PMC6328478,Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.,Front Pediatr,2024-02-14-09-13-23,True
30683910,PMC6755969,Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.,Leukemia,2024-02-14-09-13-26,True
30683910,PMC6755969,Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.,Leukemia,2024-02-14-09-13-23,True
30705877,PMC6344448,Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.,Front Pediatr,2024-02-14-09-13-26,True
30705877,PMC6344448,Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.,Front Pediatr,2024-02-14-09-13-23,True
30727780,PMC6421368,Extranodal NK/T-cell lymphoma in adolescents: imaging findings of a consecutive 7-year case series.,J Int Med Res,2024-02-14-09-13-23,True
30727780,PMC6421368,Extranodal NK/T-cell lymphoma in adolescents: imaging findings of a consecutive 7-year case series.,J Int Med Res,2024-02-14-09-13-26,True
30774427,PMC6350644,Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.,Cancer Manag Res,2024-02-14-09-13-23,True
30774427,PMC6350644,Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.,Cancer Manag Res,2024-02-14-09-13-26,True
30791900,PMC6385406,The impact of early diagnosis on the prognosis of extranodal NK/T-cell lymphoma with massive lung involvement: a case report.,BMC Pulm Med,2024-02-14-09-13-23,True
30791900,PMC6385406,The impact of early diagnosis on the prognosis of extranodal NK/T-cell lymphoma with massive lung involvement: a case report.,BMC Pulm Med,2024-02-14-09-13-26,True
30809508,PMC6379266,"EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment.",Front Oncol,2024-02-14-09-13-23,True
30809508,PMC6379266,"EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment.",Front Oncol,2024-02-14-09-13-26,True
30882662,PMC6426610,Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.,Medicine (Baltimore),2024-02-14-09-13-23,True
30882662,PMC6426610,Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.,Medicine (Baltimore),2024-02-14-09-13-26,True
30882662,PMC6426610,Primary adrenal extranasal NK/T cell lymphoma with subcutaneous involvement demonstrated on FDG PET/CT: A clinical case report.,Medicine (Baltimore),2024-02-14-09-13-20,True
30882672,PMC6426616,"A case report of an extranodal NK/T-cell lymphoma nasal type, occurring primarily in eyes with masquerade syndrome.",Medicine (Baltimore),2024-02-14-09-13-23,True
30882672,PMC6426616,"A case report of an extranodal NK/T-cell lymphoma nasal type, occurring primarily in eyes with masquerade syndrome.",Medicine (Baltimore),2024-02-14-09-13-26,True
30918142,PMC6528137,"A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma.",J Clin Exp Hematop,2024-02-14-09-13-23,True
30918142,PMC6528137,"A Case of Composite Lymphoma with Extranodal NK/T-cell Lymphoma, Nasal-type and Diffuse Large B-cell Lymphoma.",J Clin Exp Hematop,2024-02-14-09-13-26,True
30931288,PMC6428722,Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.,Front Pediatr,2024-02-14-09-13-26,True
30931288,PMC6428722,Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.,Front Pediatr,2024-02-14-09-13-23,True
30935402,PMC6444858,Molecular pathogenic pathways in extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-23,True
30935402,PMC6444858,Molecular pathogenic pathways in extranodal NK/T cell lymphoma.,J Hematol Oncol,2024-02-14-09-13-26,True
30971067,PMC6790852,"Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.",Cancer Res Treat,2024-02-14-09-13-26,True
30971067,PMC6790852,"Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience.",Cancer Res Treat,2024-02-14-09-13-23,True
31002364,PMC6488994,"JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.",Oncol Rep,2024-02-14-09-13-23,True
31002364,PMC6488994,"JAK3/STAT3 oncogenic pathway and PRDM1 expression stratify clinicopathologic features of extranodal NK/T‑cell lymphoma, nasal type.",Oncol Rep,2024-02-14-09-13-26,True
31118779,PMC6497975,"Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.",Cancer Manag Res,2024-02-14-09-13-23,True
31118779,PMC6497975,"Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III-IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus.",Cancer Manag Res,2024-02-14-09-13-26,True
31190991,PMC6511611,Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.,Cancer Manag Res,2024-02-14-09-13-26,True
31190991,PMC6511611,Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.,Cancer Manag Res,2024-02-14-09-13-23,True
31292228,PMC6620372,High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.,mSphere,2024-02-14-09-13-26,True
31292228,PMC6620372,High-Throughput Sequence Analysis of Peripheral T-Cell Lymphomas Indicates Subtype-Specific Viral Gene Expression Patterns and Immune Cell Microenvironments.,mSphere,2024-02-14-09-13-23,True
31320868,PMC6616089,"Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type.",Case Rep Dermatol,2024-02-14-09-13-23,True
31320868,PMC6616089,"Mosquito Bite-Induced Localized NK/T-Cell Lymphoma Relapsed in a Patient with Complete Remission of Extranodal NK/T-Cell Lymphoma, Nasal Type.",Case Rep Dermatol,2024-02-14-09-13-26,True
31413056,PMC6700548,Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.,BMJ Case Rep,2024-02-14-09-13-26,True
31413056,PMC6700548,Sinonasal relapses of a primary isolated extranodal NK/T-cell lymphoma of the testis.,BMJ Case Rep,2024-02-14-09-13-23,True
31628410,PMC6802199,A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study.,Sci Rep,2024-02-14-09-13-23,True
31628410,PMC6802199,A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study.,Sci Rep,2024-02-14-09-13-26,True
31649489,PMC6805491,The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.,Cancer Cell Int,2024-02-14-09-13-23,True
31649489,PMC6805491,The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.,Cancer Cell Int,2024-02-14-09-13-26,True
31804361,PMC6919438,Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.,Medicine (Baltimore),2024-02-14-09-13-26,True
31804361,PMC6919438,Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.,Medicine (Baltimore),2024-02-14-09-13-20,True
31804361,PMC6919438,Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.,Medicine (Baltimore),2024-02-14-09-13-23,True
31840047,PMC6902387,"Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type.",Acad Pathol,2024-02-14-09-13-23,True
31840047,PMC6902387,"Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type.",Acad Pathol,2024-02-14-09-13-26,True
31856438,PMC7342370,[14-3-3ζ protein mediates gemcitabine resistance in NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
31856438,PMC7342370,[14-3-3ζ protein mediates gemcitabine resistance in NK/T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
31895825,PMC6946263,Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.,Medicine (Baltimore),2024-02-14-09-13-23,True
31895825,PMC6946263,Recurrence of nasal type NK/T cell lymphoma presenting as neurolymphomatosis on 18F-FDG PET/CT: A case report and literature review.,Medicine (Baltimore),2024-02-14-09-13-26,True
31908105,PMC7060462,Efficient recruitment of c-FLIP(L) to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma.,Cancer Sci,2024-02-14-09-13-23,True
31908105,PMC7060462,Efficient recruitment of c-FLIP(L) to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma.,Cancer Sci,2024-02-14-09-13-26,True
31969793,PMC6964055,Correction to: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.,Cancer Cell Int,2024-02-14-09-13-26,True
31969793,PMC6964055,Correction to: The predictive value of dynamic monitoring of peripheral blood lymphocyte to monocyte ratio in patients with extranodal NK/T cell lymphoma.,Cancer Cell Int,2024-02-14-09-13-23,True
31998645,PMC6966716,Proteomic Analysis of Cerebrospinal Fluid From Patients With Extranodal NK-/T-Cell Lymphoma of Nasal-Type With Ethmoidal Sinus Metastasis.,Front Oncol,2024-02-14-09-13-23,True
31998645,PMC6966716,Proteomic Analysis of Cerebrospinal Fluid From Patients With Extranodal NK-/T-Cell Lymphoma of Nasal-Type With Ethmoidal Sinus Metastasis.,Front Oncol,2024-02-14-09-13-26,True
32098335,PMC7073055,Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.,Int J Mol Sci,2024-02-14-09-13-26,True
32098335,PMC7073055,Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis.,Int J Mol Sci,2024-02-14-09-13-23,True
32152465,PMC7787971,Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.,Leukemia,2024-02-14-09-13-26,True
32152465,PMC7787971,Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.,Leukemia,2024-02-14-09-13-23,True
32384485,PMC7440048,Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome.,Medicine (Baltimore),2024-02-14-09-13-23,True
32384485,PMC7440048,Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome.,Medicine (Baltimore),2024-02-14-09-13-26,True
32519518,PMC7402823,"Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients.",Cancer Med,2024-02-14-09-13-26,True
32519518,PMC7402823,"Radiotherapy followed by DICEP regimen in treatment of newly diagnosed, stage IE/IIE, extranodal NK/T-cell lymphoma patients.",Cancer Med,2024-02-14-09-13-23,True
32536145,PMC7342071,[Extranodal NK/T-cell lymphoma involving the central nervous system in two cases and literature review].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
32536145,PMC7342071,[Extranodal NK/T-cell lymphoma involving the central nervous system in two cases and literature review].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
32562035,PMC7410867,Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI.,Neuroradiology,2024-02-14-09-13-26,True
32562035,PMC7410867,Differential diagnosis of sinonasal extranodal NK/T cell lymphoma and diffuse large B cell lymphoma on MRI.,Neuroradiology,2024-02-14-09-13-23,True
32627928,PMC7648361,"Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.",Oncologist,2024-02-14-09-13-23,True
32627928,PMC7648361,"Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.",Oncologist,2024-02-14-09-13-26,True
32654458,PMC7378296,[Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
32654458,PMC7378296,[Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
32695399,PMC7366898,Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.,Biomark Res,2024-02-14-09-13-23,True
32695399,PMC7366898,Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.,Biomark Res,2024-02-14-09-13-26,True
32719179,PMC7386895,Extranodal NK/T cell lymphoma.,Blood Res,2024-02-14-09-13-23,True
32719179,PMC7386895,Extranodal NK/T cell lymphoma.,Blood Res,2024-02-14-09-13-26,True
32782583,PMC7401002,"Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection.",Oncol Lett,2024-02-14-09-13-23,True
32782583,PMC7401002,"Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection.",Oncol Lett,2024-02-14-09-13-26,True
32911592,PMC8225494,Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma.,Yeungnam Univ J Med,2024-02-14-09-13-23,True
32911592,PMC8225494,Metachronous extranodal natural killer/T-cell lymphoma of nasal type and primary testicular lymphoma.,Yeungnam Univ J Med,2024-02-14-09-13-26,True
32943751,PMC8179849,Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.,Leukemia,2024-02-14-09-13-23,True
32943751,PMC8179849,Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study.,Leukemia,2024-02-14-09-13-26,True
32956336,PMC7520134,"Natural Killer (NK)//T-Cell Lymphoma, Nasal Type, with Periorbital Involvement: A Case Report and Literature Review.",Am J Case Rep,2024-02-14-09-13-23,True
32956336,PMC7520134,"Natural Killer (NK)//T-Cell Lymphoma, Nasal Type, with Periorbital Involvement: A Case Report and Literature Review.",Am J Case Rep,2024-02-14-09-13-26,True
33024692,PMC7527573,Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature review.,Leuk Res Rep,2024-02-14-09-13-26,True
33024692,PMC7527573,Primary adrenal extranodal NK/T-cell lymphoma: A case report and literature review.,Leuk Res Rep,2024-02-14-09-13-23,True
33025280,PMC7538035,Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.,J Cancer Res Clin Oncol,2024-02-14-09-13-26,True
33025280,PMC7538035,Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.,J Cancer Res Clin Oncol,2024-02-14-09-13-23,True
33102056,PMC7573970,A nasal swelling revealing a metastatic testicular extranodal NK/T-cell lymphoma: A case report and a review of literature.,Urol Case Rep,2024-02-14-09-13-23,True
33102056,PMC7573970,A nasal swelling revealing a metastatic testicular extranodal NK/T-cell lymphoma: A case report and a review of literature.,Urol Case Rep,2024-02-14-09-13-26,True
33178609,PMC7591820,"Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type.",Front Oncol,2024-02-14-09-13-23,True
33178609,PMC7591820,"Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type.",Front Oncol,2024-02-14-09-13-26,True
33190438,PMC7656077,"[Clinical characteristics and survival analysis of primary intestinal extranodal NK/T-cell lymphoma, nasal type].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
33190438,PMC7656077,"[Clinical characteristics and survival analysis of primary intestinal extranodal NK/T-cell lymphoma, nasal type].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
33191193,PMC7876686,Splenic lymphoma with complex gastro-spleno-diaphragmatic fistula: 3D laparoscopic multivisceral resection. The first literature case report.,Int J Surg Case Rep,2024-02-14-09-13-23,True
33191193,PMC7876686,Splenic lymphoma with complex gastro-spleno-diaphragmatic fistula: 3D laparoscopic multivisceral resection. The first literature case report.,Int J Surg Case Rep,2024-02-14-09-13-26,True
33261029,PMC7761501,Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-23,True
33261029,PMC7761501,Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-26,True
33330083,PMC7734249,Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma.,Front Oncol,2024-02-14-09-13-23,True
33330083,PMC7734249,Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma.,Front Oncol,2024-02-14-09-13-26,True
33344487,PMC7744785,Serous Effusions Diagnostic Accuracy for Hematopoietic Malignancies: A Cyto-Histological Correlation.,Front Med (Lausanne),2024-02-14-09-13-23,True
33344487,PMC7744785,Serous Effusions Diagnostic Accuracy for Hematopoietic Malignancies: A Cyto-Histological Correlation.,Front Med (Lausanne),2024-02-14-09-13-26,True
33391513,PMC7738865,LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma.,Theranostics,2024-02-14-09-13-23,True
33391513,PMC7738865,LncRNA BCYRN1-induced autophagy enhances asparaginase resistance in extranodal NK/T-cell lymphoma.,Theranostics,2024-02-14-09-13-26,True
33407170,PMC7789587,Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.,BMC Gastroenterol,2024-02-14-09-13-26,True
33407170,PMC7789587,Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.,BMC Gastroenterol,2024-02-14-09-13-23,True
33445857,PMC7840558,"[Intraocular involvement of extranodal NK/T-cell lymphoma, nasal type: two cases report].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
33445857,PMC7840558,"[Intraocular involvement of extranodal NK/T-cell lymphoma, nasal type: two cases report].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
33535731,PMC8171200,Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.,Turk J Haematol,2024-02-14-09-13-23,True
33535731,PMC8171200,Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma.,Turk J Haematol,2024-02-14-09-13-26,True
33623433,PMC7896804,The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.,Cancer Manag Res,2024-02-14-09-13-23,True
33623433,PMC7896804,The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.,Cancer Manag Res,2024-02-14-09-13-26,True
33663601,PMC7934377,Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report.,J Med Case Rep,2024-02-14-09-13-26,True
33663601,PMC7934377,Atezolizumab in combination with intrathecal chemotherapy and radiation for treatment of isolated cerebral nervous system relapse in a patient with extranodal NK/T cell lymphoma: a case report.,J Med Case Rep,2024-02-14-09-13-23,True
33723329,PMC7960964,Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping.,Sci Rep,2024-02-14-09-13-26,True
33723329,PMC7960964,Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping.,Sci Rep,2024-02-14-09-13-23,True
33725836,PMC7969288,"Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.",Medicine (Baltimore),2024-02-14-09-13-23,True
33725836,PMC7969288,"Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.",Medicine (Baltimore),2024-02-14-09-13-26,True
33808787,PMC8003370,EBV and the Pathogenesis of NK/T Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-26,True
33808787,PMC8003370,EBV and the Pathogenesis of NK/T Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-23,True
33816224,PMC8010170,Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations.,Front Oncol,2024-02-14-09-13-26,True
33816224,PMC8010170,Case Report: Primary NK/T Cell Lymphoma Nasal Type of the Colon With Multiple Intestinal Perforations.,Front Oncol,2024-02-14-09-13-23,True
33911681,PMC7997061,Extranodal NK/T-Cell Lymphoma Mimicking an Infectious Granuloma.,Ann Dermatol,2024-02-14-09-13-23,True
33911681,PMC7997061,Extranodal NK/T-Cell Lymphoma Mimicking an Infectious Granuloma.,Ann Dermatol,2024-02-14-09-13-26,True
33926575,PMC8086114,Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literature.,J Med Case Rep,2024-02-14-09-13-23,True
33926575,PMC8086114,Combined immune checkpoint blockade and radiotherapy induces durable remission in relapsed natural killer/T-cell lymphoma: a case report and review of the literature.,J Med Case Rep,2024-02-14-09-13-26,True
33968824,PMC8087349,"Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement.",Autops Case Rep,2024-02-14-09-13-23,True
33968824,PMC8087349,"Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement.",Autops Case Rep,2024-02-14-09-13-26,True
33990633,PMC8121831,EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.,Sci Rep,2024-02-14-09-13-23,True
33990633,PMC8121831,EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.,Sci Rep,2024-02-14-09-13-26,True
34026185,PMC8133067,Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.,Clin Case Rep,2024-02-14-09-13-23,True
34026185,PMC8133067,Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.,Clin Case Rep,2024-02-14-09-13-26,True
34072328,PMC8199162,Primary Gastrointestinal T/NK Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-26,True
34072328,PMC8199162,Primary Gastrointestinal T/NK Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-23,True
34112087,PMC8191100,Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal symptoms in patients with normal immunity: a case report and literature review.,BMC Gastroenterol,2024-02-14-09-13-23,True
34112087,PMC8191100,Clinical features of NK/T-cell EBV-associated LPD manifested as gastrointestinal symptoms in patients with normal immunity: a case report and literature review.,BMC Gastroenterol,2024-02-14-09-13-26,True
34158320,PMC8220452,"Extranodal NK/T cell lymphoma, nasal type: a rare diagnosis with common nasal presentation.",BMJ Case Rep,2024-02-14-09-13-23,True
34158320,PMC8220452,"Extranodal NK/T cell lymphoma, nasal type: a rare diagnosis with common nasal presentation.",BMJ Case Rep,2024-02-14-09-13-26,True
34160395,PMC8238288,An unusual extranodal natural killer/T-cell lymphoma presenting as chronic laryngitis: A case report.,Medicine (Baltimore),2024-02-14-09-13-20,True
34160395,PMC8238288,An unusual extranodal natural killer/T-cell lymphoma presenting as chronic laryngitis: A case report.,Medicine (Baltimore),2024-02-14-09-13-26,True
34160395,PMC8238288,An unusual extranodal natural killer/T-cell lymphoma presenting as chronic laryngitis: A case report.,Medicine (Baltimore),2024-02-14-09-13-23,True
34164483,PMC8184435,"Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatomical sites: a population-based study.",Ann Transl Med,2024-02-14-09-13-23,True
34164483,PMC8184435,"Survival trends for extranodal NK/T-cell lymphoma, nasal type from different anatomical sites: a population-based study.",Ann Transl Med,2024-02-14-09-13-26,True
34202088,PMC8304202,"Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation.",Microorganisms,2024-02-14-09-13-26,True
34202088,PMC8304202,"Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation.",Microorganisms,2024-02-14-09-13-23,True
34235215,PMC8216793,Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.,Biomed Res Int,2024-02-14-09-13-26,True
34235215,PMC8216793,Primary Cutaneous Lymphomas in Thailand: A 10-Year Retrospective Study.,Biomed Res Int,2024-02-14-09-13-23,True
34277451,PMC8285057,Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report.,Front Oncol,2024-02-14-09-13-26,True
34277451,PMC8285057,Successful Outcome of Programmed Death 1 Blockade Plus GemOx for Epstein-Barr Virus-Associated Primary Nodal T/NK Cell Lymphoma: A Case Report.,Front Oncol,2024-02-14-09-13-23,True
34306131,PMC8298046,Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature.,Iran J Pathol,2024-02-14-09-13-23,True
34306131,PMC8298046,Cardiac Involvement and Subsequent Death due to Extranodal NK/T Cell Cutaneous T-Cell Lymphoma: An Autopsy Case and Brief Review of the Literature.,Iran J Pathol,2024-02-14-09-13-26,True
34447273,PMC8384145,Extranodal NK/T-Cell Lymphoma Occurring Primarily in the Eyes and with Central Nervous System Relapse.,Cancer Manag Res,2024-02-14-09-13-26,True
34447273,PMC8384145,Extranodal NK/T-Cell Lymphoma Occurring Primarily in the Eyes and with Central Nervous System Relapse.,Cancer Manag Res,2024-02-14-09-13-23,True
34455746,PMC8408497,[Clinicopathological features of intravascular peripheral T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
34455746,PMC8408497,[Clinicopathological features of intravascular peripheral T-cell lymphoma].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
34455749,PMC8408487,"[The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,True
34455749,PMC8408487,"[The expression and prognostic value of PD-1, TIM-3, LAG-3 and BTLA in extranodal NK/T cell lymphoma].",Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,True
34461835,PMC8404326,Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.,BMC Cancer,2024-02-14-09-13-26,True
34461835,PMC8404326,Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing.,BMC Cancer,2024-02-14-09-13-23,True
34490105,PMC8416502,"How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.",Front Oncol,2024-02-14-09-13-26,True
34490105,PMC8416502,"How to Identify Patients at High Risk of Developing Nasal-Type, Extranodal Nature Killer/T-Cell Lymphoma-Associated Hemophagocytic Syndrome.",Front Oncol,2024-02-14-09-13-23,True
34568086,PMC8461088,"Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type.",Front Cell Infect Microbiol,2024-02-14-09-13-26,True
34568086,PMC8461088,"Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type.",Front Cell Infect Microbiol,2024-02-14-09-13-23,True
34702349,PMC8549221,Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.,J Med Case Rep,2024-02-14-09-13-26,True
34702349,PMC8549221,Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.,J Med Case Rep,2024-02-14-09-13-23,True
34702811,PMC8548511,"Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4).",Signal Transduct Target Ther,2024-02-14-09-13-23,True
34702811,PMC8548511,"Sintilimab for relapsed/refractory extranodal NK/T cell lymphoma: a multicenter, single-arm, phase 2 trial (ORIENT-4).",Signal Transduct Target Ther,2024-02-14-09-13-26,True
34705104,PMC8752571,Estimating the global burden of Epstein-Barr virus-related cancers.,J Cancer Res Clin Oncol,2024-02-14-09-13-23,True
34705104,PMC8752571,Estimating the global burden of Epstein-Barr virus-related cancers.,J Cancer Res Clin Oncol,2024-02-14-09-13-26,True
34749754,PMC8573996,Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.,Diagn Pathol,2024-02-14-09-13-23,True
34749754,PMC8573996,Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.,Diagn Pathol,2024-02-14-09-13-26,True
34794461,PMC8600691,Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.,Orphanet J Rare Dis,2024-02-14-09-13-26,True
34794461,PMC8600691,Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.,Orphanet J Rare Dis,2024-02-14-09-13-23,True
34872521,PMC8650233,The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.,BMC Cancer,2024-02-14-09-13-23,True
34872521,PMC8650233,The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.,BMC Cancer,2024-02-14-09-13-26,True
34880297,PMC8655014,Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.,Sci Rep,2024-02-14-09-13-23,True
34880297,PMC8655014,Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.,Sci Rep,2024-02-14-09-13-26,True
34885131,PMC8656853,EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).,Cancers (Basel),2024-02-14-09-13-23,True
34885131,PMC8656853,EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3).,Cancers (Basel),2024-02-14-09-13-26,True
34927072,PMC8671822,An Unusual Case of EBV-Negative Primary CNS Lymphoma of Natural Killer/T-Cell Lineage.,Clin Pathol,2024-02-14-09-13-23,True
34927072,PMC8671822,An Unusual Case of EBV-Negative Primary CNS Lymphoma of Natural Killer/T-Cell Lineage.,Clin Pathol,2024-02-14-09-13-26,True
34930176,PMC8690966,Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.,BMC Cancer,2024-02-14-09-13-23,True
34930176,PMC8690966,Utility of a new notation to visualize flow cytometry analysis results: first preliminary comparison with immunohistochemistry to detect CD30 expression on T-cell lymphoma cells.,BMC Cancer,2024-02-14-09-13-26,True
35002118,PMC8670456,Extranodal NK/T Cell Lymphoma Presenting as Premaxillary Swelling: A Cytological Diagnosis.,J Cytol,2024-02-14-09-13-23,True
35002118,PMC8670456,Extranodal NK/T Cell Lymphoma Presenting as Premaxillary Swelling: A Cytological Diagnosis.,J Cytol,2024-02-14-09-13-26,True
35021606,PMC9335103,Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.,Haematologica,2024-02-14-09-13-23,True
35021606,PMC9335103,Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.,Haematologica,2024-02-14-09-13-26,True
35023929,PMC8747803,Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review.,Onco Targets Ther,2024-02-14-09-13-26,True
35023929,PMC8747803,Successful Treatment of Primary CNS Extranodal NK/T-Cell Lymphoma with Surgery and Chemotherapy Combined with Sintilimab: A Case Report and Literature Review.,Onco Targets Ther,2024-02-14-09-13-23,True
35054466,PMC8781285,The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.,Life (Basel),2024-02-14-09-13-23,True
35054466,PMC8781285,The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma.,Life (Basel),2024-02-14-09-13-26,True
35071774,PMC8729226,The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma.,Open Med (Wars),2024-02-14-09-13-26,True
35071774,PMC8729226,The biomarkers of key miRNAs and gene targets associated with extranodal NK/T-cell lymphoma.,Open Med (Wars),2024-02-14-09-13-23,True
35115837,PMC8805738,New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma.,Cancer Manag Res,2024-02-14-09-13-26,True
35115837,PMC8805738,New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma.,Cancer Manag Res,2024-02-14-09-13-23,True
35117335,PMC8798242,Primary pulmonary extranodal NK/T-cell lymphoma: a case report and literature review.,Transl Cancer Res,2024-02-14-09-13-26,True
35117335,PMC8798242,Primary pulmonary extranodal NK/T-cell lymphoma: a case report and literature review.,Transl Cancer Res,2024-02-14-09-13-23,True
35117598,PMC8798300,Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.,Transl Cancer Res,2024-02-14-09-13-26,True
35117598,PMC8798300,Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.,Transl Cancer Res,2024-02-14-09-13-23,True
35141162,PMC8818987,"Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.",Front Oncol,2024-02-14-09-13-23,True
35141162,PMC8818987,"Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination.",Front Oncol,2024-02-14-09-13-26,True
35204500,PMC8871212,Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine.,Diagnostics (Basel),2024-02-14-09-13-26,True
35204500,PMC8871212,Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine.,Diagnostics (Basel),2024-02-14-09-13-23,True
35242264,PMC8885377,Extranodal nasal NK/T cell lymphoma with bronchial mucoepidermoid carcinoma and lung adenocarcinoma: a case report.,Radiol Case Rep,2024-02-14-09-13-26,True
35242264,PMC8885377,Extranodal nasal NK/T cell lymphoma with bronchial mucoepidermoid carcinoma and lung adenocarcinoma: a case report.,Radiol Case Rep,2024-02-14-09-13-23,True
35242496,PMC8888118,Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma.,Anal Cell Pathol (Amst),2024-02-14-09-13-26,True
35242496,PMC8888118,Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma.,Anal Cell Pathol (Amst),2024-02-14-09-13-23,True
35252002,PMC8888904,Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma.,Front Oncol,2024-02-14-09-13-26,True
35252002,PMC8888904,Progress of Hematopoietic Stem Cell Transplantation and Radiotherapy in the Treatment of Extranodal NK/T Cell Lymphoma.,Front Oncol,2024-02-14-09-13-23,True
35371331,PMC8965112,Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma.,J Cancer,2024-02-14-09-13-23,True
35371331,PMC8965112,Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma.,J Cancer,2024-02-14-09-13-26,True
35386791,PMC8977926,A case report of Extranodal natural killer / T-cell lymphoma presenting as extensive myiasis.,Ann Med Surg (Lond),2024-02-14-09-13-23,True
35386791,PMC8977926,A case report of Extranodal natural killer / T-cell lymphoma presenting as extensive myiasis.,Ann Med Surg (Lond),2024-02-14-09-13-26,True
35489119,PMC9062442,Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen.,Transl Oncol,2024-02-14-09-13-20,True
35489119,PMC9062442,Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen.,Transl Oncol,2024-02-14-09-13-26,True
35489119,PMC9062442,Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen.,Transl Oncol,2024-02-14-09-13-23,True
35602784,PMC9116688,"Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type.",Cureus,2024-02-14-09-13-23,True
35602784,PMC9116688,"Recurrence 14 Years After Initial Treatment of Extranodal NK/T Cell Lymphoma, Nasal Type.",Cureus,2024-02-14-09-13-26,True
35626087,PMC9139583,Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.,Cancers (Basel),2024-02-14-09-13-23,True
35626087,PMC9139583,Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.,Cancers (Basel),2024-02-14-09-13-26,True
35783622,PMC9248758,"Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.",Front Med (Lausanne),2024-02-14-09-13-23,True
35783622,PMC9248758,"Rhino-Orbital-Cerebral Mycosis and Extranodal Natural Killer or/and T-Cell Lymphoma, Nasal Type.",Front Med (Lausanne),2024-02-14-09-13-26,True
35844703,PMC9176061,Leukemic presentation of extranodal NK/T-cell lymphoma.,EJHaem,2024-02-14-09-13-23,True
35844703,PMC9176061,Leukemic presentation of extranodal NK/T-cell lymphoma.,EJHaem,2024-02-14-09-13-26,True
35844719,PMC9176005,Laryngeal recurrence of extranodal NK/T cell lymphoma.,EJHaem,2024-02-14-09-13-26,True
35844719,PMC9176005,Laryngeal recurrence of extranodal NK/T cell lymphoma.,EJHaem,2024-02-14-09-13-23,True
35882439,PMC9837655,Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.,Blood Adv,2024-02-14-09-13-23,True
35882439,PMC9837655,Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.,Blood Adv,2024-02-14-09-13-26,True
35950145,PMC9294926,Nonhealing Ulcers with Rimming of the Adipose Tissues.,Case Rep Dermatol,2024-02-14-09-13-26,True
35950145,PMC9294926,Nonhealing Ulcers with Rimming of the Adipose Tissues.,Case Rep Dermatol,2024-02-14-09-13-23,True
35965550,PMC9372794,(18)F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma.,Front Oncol,2024-02-14-09-13-23,True
35965550,PMC9372794,(18)F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma.,Front Oncol,2024-02-14-09-13-26,True
35979577,PMC9635036,Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma.,J Clin Exp Hematop,2024-02-14-09-13-23,True
35979577,PMC9635036,Surface CD3-negative monomorphic epitheliotropic intestinal T-cell lymphoma.,J Clin Exp Hematop,2024-02-14-09-13-26,True
36045925,PMC9423101,Case report: Cytokine hemoadsorption in a case of hemophagocytic lymphohistiocytosis secondary to extranodal NK/T-cell lymphoma.,Front Med (Lausanne),2024-02-14-09-13-26,True
36045925,PMC9423101,Case report: Cytokine hemoadsorption in a case of hemophagocytic lymphohistiocytosis secondary to extranodal NK/T-cell lymphoma.,Front Med (Lausanne),2024-02-14-09-13-23,True
36111075,PMC9470109,Cardiac relapse of extranodal NK/T-cell lymphoma manifesting as incessant ventricular tachycardia: a case report.,Eur Heart J Case Rep,2024-02-14-09-13-23,True
36111075,PMC9470109,Cardiac relapse of extranodal NK/T-cell lymphoma manifesting as incessant ventricular tachycardia: a case report.,Eur Heart J Case Rep,2024-02-14-09-13-26,True
36114786,PMC9939185,Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020.,Cancer Med,2024-02-14-09-13-26,True
36114786,PMC9939185,Real-World clinical features and survival outcomes associated with primary gastrointestinal natural killer/T-cell lymphoma from 1999 to 2020.,Cancer Med,2024-02-14-09-13-23,True
36135102,PMC9497790,"Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases.",Dermatopathology (Basel),2024-02-14-09-13-23,True
36135102,PMC9497790,"Cutaneous Involvement of Extranodal NK/T Cell Lymphoma, Nasal Type, a Clinical and Histopathological Mimicker of Various Skin Diseases.",Dermatopathology (Basel),2024-02-14-09-13-26,True
36181669,PMC9828511,The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.,Cancer,2024-02-14-09-13-26,True
36181669,PMC9828511,The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.,Cancer,2024-02-14-09-13-20,True
36181669,PMC9828511,The value of routine bone marrow examination in patients with extranodal NK/T-cell lymphoma staged with PET/CT.,Cancer,2024-02-14-09-13-23,True
36199094,PMC9533626,"Primary small intestinal extranodal NK/T cell lymphoma, nasal type with kidney involvement: a rare case report and literature review.",Diagn Pathol,2024-02-14-09-13-23,True
36199094,PMC9533626,"Primary small intestinal extranodal NK/T cell lymphoma, nasal type with kidney involvement: a rare case report and literature review.",Diagn Pathol,2024-02-14-09-13-26,True
36246799,PMC9561561,Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.,World J Clin Cases,2024-02-14-09-13-23,True
36246799,PMC9561561,Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1: A case report.,World J Clin Cases,2024-02-14-09-13-26,True
36275709,PMC9585235,Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein-Barr virus infection: A case-based review.,Front Immunol,2024-02-14-09-13-23,True
36275709,PMC9585235,Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein-Barr virus infection: A case-based review.,Front Immunol,2024-02-14-09-13-26,True
36303126,PMC9609466,"Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.",BMC Cancer,2024-02-14-09-13-23,True
36303126,PMC9609466,"Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells.",BMC Cancer,2024-02-14-09-13-26,True
36326691,PMC9699755,Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation.,Aging (Albany NY),2024-02-14-09-13-26,True
36326691,PMC9699755,Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation.,Aging (Albany NY),2024-02-14-09-13-23,True
36336765,PMC9852223,Extranodal T- and NK-cell lymphomas.,Virchows Arch,2024-02-14-09-13-23,True
36336765,PMC9852223,Extranodal T- and NK-cell lymphomas.,Virchows Arch,2024-02-14-09-13-26,True
36358876,PMC9658079,"Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease.",Cancers (Basel),2024-02-14-09-13-23,True
36358876,PMC9658079,"Intravascular NK/T-Cell Lymphoma: What We Know about This Diagnostically Challenging, Aggressive Disease.",Cancers (Basel),2024-02-14-09-13-26,True
36428710,PMC9688922,Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-23,True
36428710,PMC9688922,Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-26,True
36446856,PMC9709053,High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.,Sci Rep,2024-02-14-09-13-23,True
36446856,PMC9709053,High-dose extended-field radiotherapy plus chemotherapy improved survival in extranodal NK/T-cell lymphoma in a real-life setting: results from the multicenter T-Cell Brazil Project.,Sci Rep,2024-02-14-09-13-26,True
36466747,PMC9709097,"Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy.",Clin Transl Radiat Oncol,2024-02-14-09-13-26,True
36466747,PMC9709097,"Feasibility of low-dose radiotherapy for patients with stage I/II extranodal NK-/T-cell lymphoma, nasal type achieving complete response after l-asparaginase-containing chemotherapy.",Clin Transl Radiat Oncol,2024-02-14-09-13-23,True
36467987,PMC9524797,Extranodal NK/T Cell Lymphoma Mimicking Behçet's Syndrome.,Rheumatol Immunol Res,2024-02-14-09-13-23,True
36467987,PMC9524797,Extranodal NK/T Cell Lymphoma Mimicking Behçet's Syndrome.,Rheumatol Immunol Res,2024-02-14-09-13-26,True
36544932,PMC9764779,Sinonasal lymphoma: A primer for otolaryngologists.,Laryngoscope Investig Otolaryngol,2024-02-14-09-13-23,True
36544932,PMC9764779,Sinonasal lymphoma: A primer for otolaryngologists.,Laryngoscope Investig Otolaryngol,2024-02-14-09-13-26,True
36568165,PMC9768479,Extranodal natural killer/T-cell lymphoma invading a patient's heart: A rare case report and literature review.,Front Oncol,2024-02-14-09-13-23,True
36568165,PMC9768479,Extranodal natural killer/T-cell lymphoma invading a patient's heart: A rare case report and literature review.,Front Oncol,2024-02-14-09-13-26,True
36570690,PMC9771254,The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma.,Hemasphere,2024-02-14-09-13-26,True
36570690,PMC9771254,The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma.,Hemasphere,2024-02-14-09-13-23,True
36578755,PMC9792044,"Extranodal NK-T-Cell Lymphoma, Nasal-Type Misdiagnosed as Erythema Multiforme with Nasal Fungal Infection.",Indian J Dermatol,2024-02-14-09-13-23,True
36578755,PMC9792044,"Extranodal NK-T-Cell Lymphoma, Nasal-Type Misdiagnosed as Erythema Multiforme with Nasal Fungal Infection.",Indian J Dermatol,2024-02-14-09-13-26,True
36605875,PMC9809421,Alveolar Rhabdomyosarcoma with CD 56 Positivity: A Mimic of Extranodal NK/T Cell Lymphoma.,J Cytol,2024-02-14-09-13-26,True
36605875,PMC9809421,Alveolar Rhabdomyosarcoma with CD 56 Positivity: A Mimic of Extranodal NK/T Cell Lymphoma.,J Cytol,2024-02-14-09-13-23,True
36613688,PMC9820319,Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.,Int J Mol Sci,2024-02-14-09-13-26,True
36613688,PMC9820319,Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers-A Focus on EBV and KSHV Life Cycles and Carcinogenesis.,Int J Mol Sci,2024-02-14-09-13-23,True
36620494,PMC9813479,Centrofacial cutaneous and oral ulcerations associated with pansinusitis.,JAAD Case Rep,2024-02-14-09-13-26,True
36620494,PMC9813479,Centrofacial cutaneous and oral ulcerations associated with pansinusitis.,JAAD Case Rep,2024-02-14-09-13-23,True
36627681,PMC9830812,NK/T-cell lymphoma with rash and peripheral neuropathy as the first manifestation: a case report and literature review.,Diagn Pathol,2024-02-14-09-13-26,True
36627681,PMC9830812,NK/T-cell lymphoma with rash and peripheral neuropathy as the first manifestation: a case report and literature review.,Diagn Pathol,2024-02-14-09-13-23,True
36676781,PMC9861188,Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature.,Medicina (Kaunas),2024-02-14-09-13-26,True
36676781,PMC9861188,Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature.,Medicina (Kaunas),2024-02-14-09-13-23,True
36699770,PMC9872566,Primary Cutaneous Anaplastic Large Cell Lymphoma With Gastric Metastasis.,Cureus,2024-02-14-09-13-23,True
36699770,PMC9872566,Primary Cutaneous Anaplastic Large Cell Lymphoma With Gastric Metastasis.,Cureus,2024-02-14-09-13-26,True
36732789,PMC9893679,Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report.,BMC Oral Health,2024-02-14-09-13-26,True
36732789,PMC9893679,Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report.,BMC Oral Health,2024-02-14-09-13-23,True
36825002,PMC9941192,Treatment of extranodal NK/T-cell lymphoma: From past to future.,Front Immunol,2024-02-14-09-13-26,True
36825002,PMC9941192,Treatment of extranodal NK/T-cell lymphoma: From past to future.,Front Immunol,2024-02-14-09-13-23,True
36845680,PMC9954142,In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas.,Front Oncol,2024-02-14-09-13-23,True
36845680,PMC9954142,In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas.,Front Oncol,2024-02-14-09-13-26,True
36866811,PMC10166885,A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.,Cancer Med,2024-02-14-09-13-23,True
36866811,PMC10166885,A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.,Cancer Med,2024-02-14-09-13-26,True
36866811,PMC10166885,A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.,Cancer Med,2024-02-14-09-13-20,True
36874085,PMC9975757,A diagnostic scoring model of ENKTCL in the nose-Waldeyer's ring based on logistic regression: Differential diagnosis from DLBCL.,Front Oncol,2024-02-14-09-13-26,True
36874085,PMC9975757,A diagnostic scoring model of ENKTCL in the nose-Waldeyer's ring based on logistic regression: Differential diagnosis from DLBCL.,Front Oncol,2024-02-14-09-13-23,True
36900160,PMC10000128,Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-26,True
36900160,PMC10000128,Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.,Cancers (Basel),2024-02-14-09-13-23,True
36908718,PMC9996724,"Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma.",Clin Med Insights Oncol,2024-02-14-09-13-26,True
36908718,PMC9996724,"Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma.",Clin Med Insights Oncol,2024-02-14-09-13-23,True
36924334,PMC10225229,A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-23,True
36924334,PMC10225229,A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-26,True
36939235,PMC10129123,"Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.",Chin Med J (Engl),2024-02-14-09-13-26,True
36939235,PMC10129123,"Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.",Chin Med J (Engl),2024-02-14-09-13-23,True
37000008,PMC10166983,Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-26,True
37000008,PMC10166983,Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-20,True
37000008,PMC10166983,Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-23,True
37093551,PMC10124685,"Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.",Int J Hematol,2024-02-14-09-13-26,True
37093551,PMC10124685,"Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.",Int J Hematol,2024-02-14-09-13-23,True
37138649,PMC10150861,Intermittent fever and cough in a 56-year-old patient: Relapsing polychondritis and extranodal NK/T-cell lymphoma.,Rheumatol Immunol Res,2024-02-14-09-13-26,True
37138649,PMC10150861,Intermittent fever and cough in a 56-year-old patient: Relapsing polychondritis and extranodal NK/T-cell lymphoma.,Rheumatol Immunol Res,2024-02-14-09-13-23,True
37138889,PMC10149821,Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.,Front Immunol,2024-02-14-09-13-26,True
37138889,PMC10149821,Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.,Front Immunol,2024-02-14-09-13-23,True
37160920,PMC10169864,Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.,Cell Death Dis,2024-02-14-09-13-26,True
37160920,PMC10169864,Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.,Cell Death Dis,2024-02-14-09-13-23,True
37252237,PMC10213411,Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma.,Front Nutr,2024-02-14-09-13-23,True
37252237,PMC10213411,Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma.,Front Nutr,2024-02-14-09-13-26,True
37306711,PMC10444649,Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.,Ann Hematol,2024-02-14-09-13-23,True
37306711,PMC10444649,Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.,Ann Hematol,2024-02-14-09-13-26,True
37306807,PMC10260716,Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study.,Surg Case Rep,2024-02-14-09-13-26,True
37306807,PMC10260716,Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study.,Surg Case Rep,2024-02-14-09-13-23,True
37486391,PMC10567983,"""Sandwich"" protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study.",Ann Hematol,2024-02-14-09-13-26,False
37486391,PMC10567983,"""Sandwich"" protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study.",Ann Hematol,2024-02-14-09-13-23,False
37529691,PMC10388588,"Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?",Front Oncol,2024-02-14-09-13-26,True
37529691,PMC10388588,"Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?",Front Oncol,2024-02-14-09-13-23,True
37539026,PMC10393801,Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma.,iScience,2024-02-14-09-13-26,True
37539026,PMC10393801,Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma.,iScience,2024-02-14-09-13-23,True
37637043,PMC10448964,Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.,Front Oncol,2024-02-14-09-13-26,True
37637043,PMC10448964,Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles.,Front Oncol,2024-02-14-09-13-23,True
37781191,PMC10538126,Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms.,Front Oncol,2024-02-14-09-13-23,False
37781191,PMC10538126,Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms.,Front Oncol,2024-02-14-09-13-26,False
37789985,PMC10545147,A Case of Acute Extensive Viral Sinusitis Secondary to Acute Epstein Barr Virus.,Eur J Case Rep Intern Med,2024-02-14-09-13-26,False
37789985,PMC10545147,A Case of Acute Extensive Viral Sinusitis Secondary to Acute Epstein Barr Virus.,Eur J Case Rep Intern Med,2024-02-14-09-13-23,False
37803837,PMC10520233,[Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-26,False
37803837,PMC10520233,[Analysis of prognostic factors of extranodal NK/T-cell lymphoma treated with pegaspargase/L-asparaginase: a multicenter retrospective study].,Zhonghua Xue Ye Xue Za Zhi,2024-02-14-09-13-23,False
37888961,PMC10637774,Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma.,Elife,2024-02-14-09-13-26,False
37888961,PMC10637774,Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma.,Elife,2024-02-14-09-13-23,False
37902266,PMC10726883,Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-23,False
37902266,PMC10726883,Comparative analysis of clinicopathologic characteristics and prognosis between nasal and nonnasal extranodal NK/T-cell lymphoma.,Cancer Med,2024-02-14-09-13-26,False
37949673,PMC10754138,Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.,Adv Sci (Weinh),2024-02-14-09-13-23,False
37949673,PMC10754138,Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.,Adv Sci (Weinh),2024-02-14-09-13-26,False
37981727,PMC10660361,Intravascular NK/T-cell lymphoma: a case report and literature review.,J Pathol Transl Med,2024-02-14-09-13-26,False
37981727,PMC10660361,Intravascular NK/T-cell lymphoma: a case report and literature review.,J Pathol Transl Med,2024-02-14-09-13-23,False
38034525,PMC10688205,Disseminated Nasal subtype Extranodal NK/T-cell lymphoma and its diagnostic difficulties in antemortem biopsies.,Autops Case Rep,2024-02-14-09-13-26,False
38034525,PMC10688205,Disseminated Nasal subtype Extranodal NK/T-cell lymphoma and its diagnostic difficulties in antemortem biopsies.,Autops Case Rep,2024-02-14-09-13-23,False
38037110,PMC10691161,The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.,Diagn Pathol,2024-02-14-09-13-23,False
38037110,PMC10691161,The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma.,Diagn Pathol,2024-02-14-09-13-26,False
38037801,PMC10690914,Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.,Haematologica,2024-02-14-09-13-26,False
38037801,PMC10690914,Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.,Haematologica,2024-02-14-09-13-23,False
38037802,PMC10690927,Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.,Haematologica,2024-02-14-09-13-23,False
38037802,PMC10690927,Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.,Haematologica,2024-02-14-09-13-26,False
38061727,PMC10727907,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Extranasal and Ulcerative Blister Variant, Case Report.",Ann Dermatol,2024-02-14-09-13-23,False
38061727,PMC10727907,"Extranodal NK/T-Cell Lymphoma, Nasal Type, Extranasal and Ulcerative Blister Variant, Case Report.",Ann Dermatol,2024-02-14-09-13-26,False
38073617,PMC10702496,Case report: Mononeuropathy multiplex of extranodal natural killer/T-cell lymphoma misdiagnosed as systemic vasculitis.,Front Neurol,2024-02-14-09-13-23,False
38073617,PMC10702496,Case report: Mononeuropathy multiplex of extranodal natural killer/T-cell lymphoma misdiagnosed as systemic vasculitis.,Front Neurol,2024-02-14-09-13-26,False
38161567,PMC10757817,"A Case of Extranodal NK/T-cell Lymphoma Infiltrating Kidneys, Presenting With Hematuria and Proteinuria With False-Positive Serum Anti-proteinase 3, and Mimicking Granulomatosis With Polyangiitis.",Cureus,2024-02-14-09-13-23,False
38161567,PMC10757817,"A Case of Extranodal NK/T-cell Lymphoma Infiltrating Kidneys, Presenting With Hematuria and Proteinuria With False-Positive Serum Anti-proteinase 3, and Mimicking Granulomatosis With Polyangiitis.",Cureus,2024-02-14-09-13-26,False
38226231,PMC10788511,Comparison of (18)F-FDG PET/CT and conventional methods in diagnosing extranodal natural killer/T-cell lymphoma.,Heliyon,2024-02-14-09-13-23,False
38226231,PMC10788511,Comparison of (18)F-FDG PET/CT and conventional methods in diagnosing extranodal natural killer/T-cell lymphoma.,Heliyon,2024-02-14-09-13-26,False
